跳至主要内容
临床试验/JPRN-UMIN000012172
JPRN-UMIN000012172招募中2 期

Multicenter phase2 clinical trial of tailored therapy according to MGMT methylation status for elderly glioblastoma patients - Multicenter phase2 clinical trial of tailored therapy according to MGMT methylation status for elderly glioblastoma patients(EGG trial)

Saitama Medical University International Medical Center0 个研究点目标入组 70 人开始时间: 2013年10月30日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Previous or concurrent cancer within 5 years, excluding carcinoma in situ, skin cancers except melanoma which was curatively treated 2) Infectious disease requiring systemic treatment 3) Psychotic disorder 4) hepatitis B virus carrier

研究者

相似试验